Kallikrein 12 antibody (Middle Region)
Quick Overview for Kallikrein 12 antibody (Middle Region) (ABIN953100)
Target
See all Kallikrein 12 (KLK12) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 84-113, Middle Region
-
Specificity
- This antibody recognizes Human KLK12 / Kallikrein-12 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 84-113 amino acids from the Central region of Human KLK12 / Kallikrein-12
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Kallikrein 12 (KLK12) (Kallikrein-Related Peptidase 12 (KLK12))
-
Alternative Name
- KLK12 / Kallikrein-12
-
Background
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Alternate splicing of this gene results in three transcript variants encoding different isoforms. [provided by RefSeq].Synonyms: KLK-L5, KLKL5, Kallikrein-like protein 5
-
Molecular Weight
- 26734 Da
-
Gene ID
- 43849
-
NCBI Accession
- NP_062544
-
Pathways
- Complement System
Target
-